Hem › Njurcancer (renalcelskarcinom) › Kalifornien › San Diego
Kliniska studier för Njurcancer (renalcelskarcinom) i San Diego, CA
14 studier för Njurcancer (renalcelskarcinom) söker deltagare vid platser i och runt San Diego (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekryterarFas 1
- Research Site, San Diego
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RekryterarFas 1
- NEO-811 San Diego Site, San Diego
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekryterarFas 1
- University of California San Diego Moores Cancer Center, La Jolla · 11 mi bort
DESTINY-PANTUMOUR04
RekryterarObservationsstudie
- Research Site, San Diego
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekryterarObservationsstudie
- University of California San Diego, La Jolla · 11 mi bort
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
RekryterarFas 2
- University of California San Diego, La Jolla · 11 mi bort
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RekryterarFas 2
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi bort
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RekryterarFas 1/2
- UC San Diego Medical Center - Bankers Hill, San Diego
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- och 5 fler
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RekryterarFas 1
- University of California San Diego Medical Center, Moores Cancer Center, La Jolla · 11 mi bort
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekryterarObservationsstudie
- University of California, San Diego, La Jolla · 11 mi bort
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekryterarFas 3
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi bort
Retifanlimab and Ruxolitinib In Solid Malignancies
RekryterarFas 1/2
- University of California, San Diego Moores Cancer Center, La Jolla · 11 mi bort
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekryterarFas 1/2
- UCSD Moores Cancer Center, La Jolla · 11 mi bort
A Beta-only IL-2 ImmunoTherapY Study
RekryterarFas 1/2
- Sharp Memorial Hospital, San Diego
Njurcancer (renalcelskarcinom)-studier i andra städer
- Houston, TX35 studier
- New York City, NY27 studier
- Nashville, TN23 studier
- Dallas, TX23 studier
- St. Louis, MO23 studier
- Los Angeles, CA20 studier
- Boston, MA16 studier
- Baldwin Park, CA16 studier
- Pittsburgh, PA15 studier
- Philadelphia, PA15 studier
- Queens, NY15 studier
- Jacksonville, FL14 studier
Andra studier i San Diego
- Icke-småcellig lungcancer48 studier
- Bröstcancer41 studier
- Cancer (alla typer)32 studier
- Prostatacancer31 studier
- Metastaserande cancer30 studier
- Kolorektal cancer25 studier
- Äggstockscancer24 studier
- Bukspottkörtelcancer24 studier
- Lungcancer23 studier
- Övervikt23 studier
- Hjärtsvikt23 studier
- Depression21 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.